Jen Fitzpatrick

Jen is SVP, General Counsel for Sionna. She brings nearly 20 years of experience advising biotechnology and pharmaceutical companies through significant clinical, regulatory and business development milestones, product launches, and capital raises.

Prior to Sionna, Jen served as VP, Corporate Counsel at Sage Therapeutics, where she built and led a team providing legal counsel and contracting support across the organization and her responsibilities spanned complex corporate transactions, securities law compliance, corporate governance, employment law matters, and investor engagement. She previously served as VP, Corporate Counsel at Aegerion Pharmaceuticals and as Corporate Counsel at AVEO Pharmaceuticals and PerkinElmer.

Jen began her legal career at Bingham McCutchen, representing public and private life sciences companies. She earned a J.D. from the University of Virginia School of Law and a B.A. from Middlebury College.